 ImmunoGen, Inc. NASDAQ:IMGN Q2 2022 Results Conference Call July 29, 2022 8:00 AM ET Company Participants Anabel Chan - Head of Investor Relations Mark Enyedy - President, CEO Anna Berkenblit - CMO Kristen Harrington-Smith - Chief Commercial Officer Susan Altschuller - CFO Conference Call Participants John Newman - Canaccord Genuity Michael Schmidt - Guggenheim Partners Etzer Darout - BMO Capital Markets Boris Peaker - Cowen Andy Hsieh - William Blair Kelly Shi - Jefferies Swayampakula Ramakanth - H.C. Wainwright Jonathan Chang - SVB Securities Operator Good morning and welcome to ImmunoGens Second Quarter 2022 Financial and Operating Results Conference Call. 